Discontinuation report APO-ALENDRONATE
Report ID | 60163 |
Drug Identification Number | 02248728 |
Brand name | APO-ALENDRONATE |
Common or Proper name | ALENDRONATE |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | ALENDRONIC ACID |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BLS |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-05-31 |
Actual discontinuation date | |
Remaining supply date | 2020-05-31 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-12-20 | French | Compare |
v7 | 2019-12-20 | English | Compare |
v6 | 2019-12-20 | French | Compare |
v5 | 2019-12-20 | English | Compare |
v4 | 2018-12-28 | French | Compare |
v3 | 2018-12-28 | English | Compare |
v2 | 2018-09-07 | French | Compare |
v1 | 2018-09-07 | English | Compare |
Showing 1 to 8 of 8